CN105125947A - Traditional Chinese medicine composition for treating prostatitis and preparing method and application of traditional Chinese medicine composition - Google Patents
Traditional Chinese medicine composition for treating prostatitis and preparing method and application of traditional Chinese medicine composition Download PDFInfo
- Publication number
- CN105125947A CN105125947A CN201510655457.0A CN201510655457A CN105125947A CN 105125947 A CN105125947 A CN 105125947A CN 201510655457 A CN201510655457 A CN 201510655457A CN 105125947 A CN105125947 A CN 105125947A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- herba
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention provides a traditional Chinese medicine composition for treating prostatitis. The traditional Chinese medicine composition is prepared from, by weight, 20-25 parts of passiflora cochinchinensis spreng, 10-15 parts of spiraea salicifolia, 18-22 parts of setaria geniculata, 14-18 parts of rubus parvifolius, 10-15 parts of pyrrosia lingua, 30-40 parts of honeysuckle, 8-16 parts of chrysanthemum, 10-15 parts of semen cuscutae and 15-25 parts of polygonum aviculare. The traditional Chinese medicine composition can clear away heat and toxic materials, promote the blood circulation to remove blood stasis and treat prostatitis. The invention further discloses a preparing method and application of the traditional Chinese medicine composition.
Description
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to one and be used for the treatment of prostatitic Chinese medicine composition and preparation method and application.
Background technology
Prostatitis is the commonly encountered diseases of Urology Surgery, in Urology Surgery male patient the right side of fifty, account for first place.Nineteen ninety-five NIH has formulated a kind of new prostatitis sorting technique, I type: be equivalent to the acute bacterial prostatitis in conventional sorting methods, II type: be equivalent to the chronic bacterial prostatitis in conventional sorting methods, III type: chronic prostatitis/chronic Pelvic Pain Syndrome, IV type: silent prostatitis.Wherein nonbacterial prostatitis is common far beyond bacterial prostatitis.Lack real effective patent medicine in the market.
Summary of the invention
Goal of the invention: in order to solve the problem, the object of the present invention is to provide one to be used for the treatment of prostatitic Chinese medicine composition and preparation method and application.
Technical scheme: the object of the invention is by following scheme realize:
One treats prostatitic Chinese medicine composition, and it is extracted by the crude drug of following parts by weight and prepares: Herba passiflorae cochinchinensis 20-25 part, Ramulus et Folium Spiraeae Salicifolia 10-15 part, Herba setariae geniculatae 18-22 part, Herba Rubi parvifolii 14-18 part, Folium Pyrrosiae 10-15 part, Flos Lonicerae 30-40 part, Flos Chrysanthemi 8-16 part, Semen Cuscutae 10-15 Fen, Herba Polygoni Avicularis 15-25 part.
The prostatitic Chinese medicine composition of described treatment, it is extracted by the crude drug of following parts by weight and prepares: Herba passiflorae cochinchinensis 22 parts, Ramulus et Folium Spiraeae Salicifolia 12 parts, Herba setariae geniculatae 20 parts, Herba Rubi parvifolii 16 parts, Folium Pyrrosiae 12 parts, Flos Lonicerae 35 parts, Flos Chrysanthemi 12 parts, Semen Cuscutae 12 Fen, Herba Polygoni Avicularis 20 parts.
The prostatitic Chinese medicine composition of described treatment, preparation method comprises the steps: that getting above-mentioned medical material merges, and decocts with water twice, amount of water is 10 times amount of medical material weight, decocts 2h, collecting decoction, when being concentrated into 65 DEG C, relative density is 1.10, adding ethanol makes the percent by volume of alcohol content reach 65%, stirs, and leaves standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.20 and reclaims ethanol, by concentrated solution spraying dry, adds adjuvant and makes capsule, tablet, granule.
The application of the prostatitic Chinese medicine composition of described treatment in preparation treatment prostatitis medicine.
Raw Herba passiflorae cochinchinensis of the present invention is Passifloraceae Passiflora plant Herba passiflorae cochinchinensis PassifloracochinchinensisSpreng., is used as medicine with Herb.The whole year can adopt, and cleans chopping, dries.Heat-clearing and toxic substances removing, reducing swelling and alleviating pain.For venom, taste-blindness rate; Panaris is controlled in external, carbuncle sore.
The upright shrub of Spiraea Rosales, Rosaceae, Classification system SpiraeaSalicifoliaL., Ramulus et Folium Spiraeae Salicifolia flower, leaf, root all can be done medicinal, can heat-clearing and toxic substances removing.For conjunctival congestion and swelling pain, headache, toothache, cough due to lung-heat; Wound hemorrhage is controlled in external.The present invention is used as medicine with Ramulus et Folium Spiraeae Salicifolia flower.
Herba setariae geniculatae is herb or the root of grass green bristlegrass Canis familiaris L. elder brother grass.Clearing away heat-damp and promoting diuresis; Removing toxic substances.
Herba Rubi parvifolii, Latin is called RubuscorchorifoliusL.f., leaf: antiinflammatory, synthetism.For severed finger.Root: dispelling, collateral-activating, heat clearing away is relieving convulsion.For infantile convulsion, bones and muscles pain due to rheumatism.The present invention uses leaf.All the other are pharmacopeia kind.
Beneficial effect:
From theory of Chinese medical science, think prostatitis pathogenesis be damp and hot retardance, drain unfavorable, in we, Herba passiflorae cochinchinensis, Ramulus et Folium Spiraeae Salicifolia, Herba setariae geniculatae, Herba Rubi parvifolii heat-clearing and toxic substances removing are monarch drug, Folium Pyrrosiae, Flos Lonicerae, Flos Chrysanthemi, Semen Cuscutae, Herba Polygoni Avicularis blood circulation promoting and blood stasis dispelling, inducing diuresis for treating stranguria syndrome, be ministerial drug altogether, all medicines are harmonious, and play clearing away heat-damp and promoting diuresis, regulating the flow of QI to dissipate blood stasis effect altogether, are used for the treatment of prostatitis.Formulation of the present invention is reasonable, and compatibility is rigorous, through long-term clinical verification, and determined curative effect.Consist of Chinese crude drug, have no side effect, low price.
Detailed description of the invention
Form by the following examples, foregoing of the present invention is described in further detail again, but this should be interpreted as that the scope of the above-mentioned theme of the present invention is only limitted to following example, all technology realized based on foregoing of the present invention all belong to scope of the present invention.
One, preparation embodiment 1: get Herba passiflorae cochinchinensis 22g, Ramulus et Folium Spiraeae Salicifolia 12g, Herba setariae geniculatae 20g, Herba Rubi parvifolii 16g, Folium Pyrrosiae 12g, Flos Lonicerae 35g, Flos Chrysanthemi 12g, Semen Cuscutae 12g, Herba Polygoni Avicularis 20g medical material merges, decoct with water twice, amount of water is 10 times amount of medical material weight, decoct 2h, collecting decoction, when being concentrated into 65 DEG C, relative density is 1.10, adding ethanol makes the percent by volume of alcohol content reach 65%, stir, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.20 and reclaims ethanol, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, leaving air temp is 80 DEG C, temperature of charge is 70 DEG C, atomizing pressure is 0.2 MPa, spray velocity is 5ml/s, add starch 50g, make capsule.
Preparation embodiment 2: get Herba passiflorae cochinchinensis 20g, Ramulus et Folium Spiraeae Salicifolia 15g, Herba setariae geniculatae 18g, Herba Rubi parvifolii 18g, Folium Pyrrosiae 10g, Flos Lonicerae 40g, Flos Chrysanthemi 8g, Semen Cuscutae 15g, Herba Polygoni Avicularis 15g medical material merges, decoct with water twice, amount of water is 10 times amount of medical material weight, decoct 2h, collecting decoction, when being concentrated into 65 DEG C, relative density is 1.10, adding ethanol makes the percent by volume of alcohol content reach 65%, stir, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.20 and reclaims ethanol, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, leaving air temp is 80 DEG C, temperature of charge is 70 DEG C, atomizing pressure is 0.2 MPa, spray velocity is 5ml/s, add starch 50g, pelletizing press sheet makes tablet.
Preparation embodiment 3: get Herba passiflorae cochinchinensis 25g, Ramulus et Folium Spiraeae Salicifolia 10g, Herba setariae geniculatae 22g, Herba Rubi parvifolii 14g, Folium Pyrrosiae 15g, Flos Lonicerae 30g, Flos Chrysanthemi 16g, Semen Cuscutae 10g, Herba Polygoni Avicularis 25g medical material merges, decoct with water twice, amount of water is 10 times amount of medical material weight, decoct 2h, collecting decoction, when being concentrated into 65 DEG C, relative density is 1.10, adding ethanol makes the percent by volume of alcohol content reach 65%, stir, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.20 and reclaims ethanol, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, leaving air temp is 80 DEG C, temperature of charge is 70 DEG C, atomizing pressure is 0.2 MPa, spray velocity is 5ml/s, add starch 50g, granule is made in granulation.
Two, the present invention is to prostatitic clinical trial data
The physical data of experimental subject: adopt the present invention to treat 50 examples altogether, the oldest person 28 years old, age reckling 16 years old is male entirely.
Diagnostic criteria: 1. urine can be had secondary slightly many, has burn feeling and urine meaning to feel not to the utmost in urethra when urinating.2. can there be sacrum portion, perineum, lower abdomen, inguinal region, urethra, testis discomfort, distending pain.Can concurrent iritis, arthritis, neuritis.3. can there is sexual disorder as libido decline, premature ejaculation, seminal emission.4. prostate touch can be normal, also can air spots, and quality is uneven, can have local tenderness.5. prostatic fluid microscopy, every high power field leukocyte is more than more than 10, and lecithin reduces or disappears.6. urine and prostatic fluid split fix cultivation and colony counting (Meares-stamey inspection technique) marginal to making a definite diagnosis.If VB1 and VB2 is negative, or <3000 bacterium number/ml, and EPS or VB, more than 5000 bacterium number/ml, when namely VB3 is more than VB12 times, just diagnosable is bacterial prostatitis; 4 specimen such as VB1 are all aseptic, and when medical history, symptom, prostate touch and massage of prostate liquid meet prostatitis diagnosis, diagnosable is aseptic prostatitis.
Therapeutic Method: usage and dosage: adopt the capsule prepared by the embodiment of the present invention 1, its usage and consumption are each 8, and every day 3 times, warm water takes, and one week are a course for the treatment of, treat for 4 courses for the treatment of altogether.
The standard of curative effect evaluation: cure: clinical manifestation transference cure, sign is improved completely, happy, in high spirits.Effective: clinical manifestation transference cure, sign makes moderate progress, and mood and spirit are better.Invalid: clinical manifestation symptom does not disappear, sign and symptom are improved not obvious or without improvement.
Experimental result: in accept for medical treatment 50 routine cases, through treatment in 1 month, wherein cures 16 examples, effective 27 examples, and invalid 7 examples, total effective rate reaches 86%.Show that the present invention has extremely significant effect to treatment prostatitis patient.
Claims (4)
1. the prostatitic Chinese medicine composition for the treatment of, it is characterized in that, it is extracted by the crude drug of following parts by weight and prepares: Herba passiflorae cochinchinensis 20-25 part, Ramulus et Folium Spiraeae Salicifolia 10-15 part, Herba setariae geniculatae 18-22 part, Herba Rubi parvifolii 14-18 part, Folium Pyrrosiae 10-15 part, Flos Lonicerae 30-40 part, Flos Chrysanthemi 8-16 part, Semen Cuscutae 10-15 Fen, Herba Polygoni Avicularis 15-25 part.
2. treat prostatitic Chinese medicine composition as claimed in claim 1, it is characterized in that, it is extracted by the crude drug of following parts by weight and prepares: Herba passiflorae cochinchinensis 22 parts, Ramulus et Folium Spiraeae Salicifolia 12 parts, Herba setariae geniculatae 20 parts, Herba Rubi parvifolii 16 parts, Folium Pyrrosiae 12 parts, Flos Lonicerae 35 parts, Flos Chrysanthemi 12 parts, Semen Cuscutae 12 Fen, Herba Polygoni Avicularis 20 parts.
3. treat prostatitic Chinese medicine composition as claimed in claim 1, it is characterized in that, preparation method comprises the steps: that getting above-mentioned medical material merges, decoct with water twice, amount of water is 10 times amount of medical material weight, decoct 2h, collecting decoction, when being concentrated into 65 DEG C, relative density is 1.10, adds ethanol and makes the percent by volume of alcohol content reach 65%, stir, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.20 and reclaims ethanol, by concentrated solution spraying dry, add adjuvant and make capsule, tablet, granule.
4. described in claim 1, treat the application of prostatitic Chinese medicine composition before the treatment in row adenitis medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510655457.0A CN105125947A (en) | 2015-10-11 | 2015-10-11 | Traditional Chinese medicine composition for treating prostatitis and preparing method and application of traditional Chinese medicine composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510655457.0A CN105125947A (en) | 2015-10-11 | 2015-10-11 | Traditional Chinese medicine composition for treating prostatitis and preparing method and application of traditional Chinese medicine composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105125947A true CN105125947A (en) | 2015-12-09 |
Family
ID=54711758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510655457.0A Withdrawn CN105125947A (en) | 2015-10-11 | 2015-10-11 | Traditional Chinese medicine composition for treating prostatitis and preparing method and application of traditional Chinese medicine composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105125947A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102233084A (en) * | 2010-05-08 | 2011-11-09 | 博安兄弟制药（中国）有限公司 | Chinese medicinal composition for treating prostatitis and preparation method thereof |
| CN104042705A (en) * | 2014-06-26 | 2014-09-17 | 南京华宽信息咨询中心 | Traditional Chinese medicine composition for treating prostatitis and preparation method and application |
-
2015
- 2015-10-11 CN CN201510655457.0A patent/CN105125947A/en not_active Withdrawn
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102233084A (en) * | 2010-05-08 | 2011-11-09 | 博安兄弟制药（中国）有限公司 | Chinese medicinal composition for treating prostatitis and preparation method thereof |
| CN104042705A (en) * | 2014-06-26 | 2014-09-17 | 南京华宽信息咨询中心 | Traditional Chinese medicine composition for treating prostatitis and preparation method and application |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102614413B (en) | Chinese medicinal composition for treating sinusitis in children and preparation method thereof | |
| CN105726635A (en) | Traditional Chinese medicine for treating nasosinusitis | |
| CN101081247A (en) | Bag infusion for drinking and for smoking to treat nose disease | |
| CN102166272B (en) | Medicament for treating hemorrhoids and preparation method thereof | |
| CN101579185B (en) | Pharmaceutical rhinitis pillow for external use and treating wind-cold rhinitis | |
| CN101129569A (en) | Orally taken traditional Chinese medicine medicinal decoction for treating acute sinusitis | |
| CN105125947A (en) | Traditional Chinese medicine composition for treating prostatitis and preparing method and application of traditional Chinese medicine composition | |
| CN104042705B (en) | One treats prostatitic Chinese medicine composition and preparation method and application | |
| CN114177231A (en) | Antipyretic pharmaceutical composition, antipyretic gel and preparation method | |
| CN105497291A (en) | Medicine composition for treating schizophrenia | |
| CN106389684A (en) | Orally-taking medicine for treating insomnia and production method thereof | |
| CN104337901A (en) | Chinese medicinal preparation for treating nonspecific cystitis and preparation method thereof | |
| CN105582134A (en) | Traditional Chinese medicine composition for treating prostatitis | |
| CN102824573B (en) | Medicine for treating prostatic diseases | |
| CN102698126B (en) | Traditional Chinese medicine compound having effect of treating prostatitis and preparation method thereof | |
| CN107095977A (en) | A kind of medicament and its pharmaceutical formulation and preparation method with the malicious effect of fire row of dispelling | |
| CN105770515A (en) | Traditional Chinese medicinal composition for treating prostatitis and preparation method of traditional Chinese medicinal composition | |
| CN105535065A (en) | Medicine composition for treating schizophrenia | |
| CN104997949A (en) | Traditional Chinese medicine for treating rhinitis and preparation method thereof | |
| CN105056057A (en) | Pharmaceutical preparation for treating bronchial asthma | |
| CN105079717A (en) | Pharmaceutical preparation for treating depression | |
| CN104491527B (en) | A kind of instant particles as Chinese medicine for treating urinary infection | |
| CN104667191A (en) | Medicinal composition for treating allergic rhinitis | |
| CN104000891B (en) | A kind of ointment for the treatment of verruca plana | |
| CN103156940B (en) | A kind of extracting technique of Chinese medicine for garden balsam stem pain-relieving |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20151209 |
|
| WW01 | Invention patent application withdrawn after publication |